TI
NVAX icon

Telemetry Investments’s Novavax NVAX Stock Holding History

Telemetry Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$181K Buy
+17,632
New +$311K 0.29% 76

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Telemetry Investments's NVAX Position: Q4 2022 in Review

Telemetry Investments opened a new position in Novavax (NVAX) in Q4 2022: 17,632 shares worth $181K. The stake represents 0.29% of the portfolio and ranks #76 among its holdings.

252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

  • Telemetry Investments held 17,632 shares of Novavax worth $181K as of Q4 2022.
  • Novavax was a new Telemetry Investments position in Q4 2022.
  • Novavax made up 0.29% of Telemetry Investments's portfolio in Q4 2022, its #76 holding.
  • 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.